The DOI matches its Crossref record; 525 of the 525 references it cites were found in a registry or an index.
Biased Receptor Signaling in Drug Discovery
Open accessAbstract
A great deal of experimental evidence suggests that ligands can stabilize different receptor active states that go on to interact with cellular signaling proteins to form a range of different complexes in varying quantities. In pleiotropically linked receptor systems, this leads to selective activation of some signaling pathways at the expense of others (biased signaling). This article summarizes the current knowledge about the complex components of receptor systems, the evidence that biased signaling is used in natural physiology to fine-tune signaling, and the current thoughts on how this mechanism may be applied to the design of better drugs. Although this is a fairly newly discovered phenomenon, theoretical and experimental data suggest that it is a ubiquitous behavior of ligands and receptors and to be expected. Biased signaling is simple to detect in vitro and there are numerous methods to quantify the effect with scales that can be used to optimize this activity in structure-activity medicinal chemistry studies. At present, the major hurdle in the application of this mechanism to therapeutics is the translation of in vitro bias to in vivo effect; this is because of the numerous factors that can modify measures of bias in natural physiologic systems. In spite of this, biased signaling still has the potential to justify revisiting of receptor targets previously thought to be intractable and also furnishes the means to pursue targets previously thought to be forbidden due to deleterious physiology (as these may be eliminated through biased signaling).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–525 of 525
Zheng, Z., Huang, X., Mangano, T. J., Zou, R., Chen, X., Zaidi, S. A., Roth, B. L., Stevens, R. C., & Katritch, V. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00109 · Cited by 59
Walther, C., & Ferguson, S. S. G. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1091 · Cited by 58
Akinaga, J., Lima, V., Kiguti, L. R. D. A., Hebeler-Barbosa, F., Alcántara-Hernández, R., García-Sáinz, J. A., & Pupo, A. S. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.082313 · Cited by 58
Re, M., Pampillo, M., Savard, M., Dubuc, C., McArdle, C. A., Millar, R. P., Conn, P. M., Gobeil, F., Bhattacharya, M. M., & Babwah, A. V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011489 · Cited by 57
Conditional Expression of a Gi-Coupled Receptor in Osteoblasts Results in Trabecular Osteopenia
Peng, J., Bencsik, M., Louie, A., Lu, W.-D., Millard, S. M., Nguyen, P., Burghardt, A. J., Majumdar, S., Wronski, T. J., Halloran, B. P., et al. (2007) · Endocrinology · doi:10.1210/en.2007-0235 · Cited by 57
Shapira, M., Vogel, Z., & Sarne, Y. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007058008477 · Cited by 57
Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor
Thompson, G. L., Lane, J. R., Coudrat, T., Sexton, P. M., Christopoulos, A., & Canals, M. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.05.014 · Cited by 57
Unett, D. J., Gatlin, J., Anthony, T. L., Buzard, D. J., Chang, S., Chen, C., Xiaohua, C., Dang, H. T., Frazer, J. M., Le, M. K., et al. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.207670 · Cited by 56
Li, Y.-T., Liu, X., Liu, C., Kang, J.-H., Yang, J.-Y., Pei, G., & Wu, C.-F. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10030954 · Cited by 55
Ensemble of G Protein-Coupled Receptor Active States
Park, P. S.-H. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799320619 · Cited by 55
Becker, G., Bolbos, R. I., Costes, N., Redouté, J., Newman‐Tancredi, A., & Zimmer, L. (2016) · Scientific Reports · doi:10.1038/srep26633 · Cited by 55
May, V., & Parsons, R. L. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25615 · Cited by 55
Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer
Elste, A. P., & Petersen, I. (2010) · Journal of Molecular Histology · doi:10.1007/s10735-010-9274-6 · Cited by 54
Monczor, F., & Fernández, N. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105981 · Cited by 54
Bonifazi, A., Yano, H., Ellenberger, M. P., Muller, L., Kumar, V., Zou, M., Cai, N. S., Guerrero, A. M., Woods, A. S., Shi, L., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01875 · Cited by 53
Is the Quest for Signaling Bias Worth the Effort?
Kenakin, T. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.111187 · Cited by 53
Self-citationSengmany, K., Singh, J., Stewart, G. D., Conn, P. J., Christopoulos, A., & Gregory, K. J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.001 · Cited by 52
Williams, P. D., Pollock, D. D., & Goldstein, R. A. (2006) · Evolutionary Bioinformatics · doi:10.1177/117693430600200013 · Cited by 52
Pharmacological Onomastics: What's in a name?
Kenakin, T. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707407 · Cited by 51
Self-citationBrulé, C., Perzo, N., Joubert, J., Sainsily, X., Leduc, R., Castel, H., & Prézeau, L. (2014) · The FASEB Journal · doi:10.1096/fj.14-249771 · Cited by 51
Johnson, T. A., Milan‐Lobo, L., Che, T., Ferwerda, M., Lambu, E., McIntosh, N. L., Li, F., He, L., Lorig‐Roach, N., Crews, P., et al. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00167 · Cited by 50
Baltos, J., Vecchio, E. A., Harris, M. A., Qin, C. X., Ritchie, R. H., Christopoulos, A., White, P. J., & May, L. T. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.03.014 · Cited by 50
Leach, K., Conigrave, A. D., Sexton, P. M., & Christopoulos, A. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.004 · Cited by 49
Faget, L. C., Erbs, E., Merrer, J. L., Scherrer, G., Matifas, A., Benturquia, N., Noble, F., Décossas, M., Koch, M., Kessler, P., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0185-12.2012 · Cited by 49
Bradley, S. J., Langmead, C. J., Watson, J. M., & Challiss, R. A. J. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.068882 · Cited by 49
Nickolls, S. A., Fleck, B. A., Hoare, S. R. J., & Maki, R. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083337 · Cited by 49
Biased signaling initiated by agouti-related peptide through human melanocortin-3 and -4 receptors
Zhao, Y., & Tao, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.05.008 · Cited by 49
Translating in vitro ligand bias into in vivo efficacy
Luttrell, L. M., Maudsley, S. R., & Gesty‐Palmer, D. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.05.002 · Cited by 49
Williams, P. D., Pollock, D. D., & Goldstein, R. A. (2007) · PubMed · Cited by 48
Functional Signaling Biases in G Protein-Coupled Receptors: Game Theory and Receptor Dynamics
Maudsley, S. R., Patel, S., Park, S.-S., Luttrell, L. M., & Martin, B. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712800959071 · Cited by 48
Walther, C., & Ferguson, S. S. G. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394440-5.00004-8 · Cited by 47
Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
Richard-Lalonde, M., Nagi, K., Audet, N., Sleno, R., Amraei, M. G., Hogue, M., Balboni, G., Schiller, P. W., Bouvier, M., Hébert, T. E., et al. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081950 · Cited by 47
Label-free integrative pharmacology on-target of drugs at the β2-adrenergic receptor
Ferrie, A. M., Sun, H., & Ye, F. (2011) · Scientific Reports · doi:10.1038/srep00033 · Cited by 47
Kenakin, T. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13217 · Cited by 45
Self-citationBiased signaling through G‐protein‐coupled PROKR2 receptors harboring missense mutations
Sbai, O., Monnier, C., Dodé, C., Pin, J., Hardelin, J., & Rondard, P. (2014) · The FASEB Journal · doi:10.1096/fj.13-243402 · Cited by 45
Koole, C., Savage, E. E., Christopoulos, A., Miller, L. J., Sexton, P. M., & Wootten, D. L. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1116 · Cited by 44
Onaran, H. O., Rajagopal, S., & Costa, T. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.010 · Cited by 44
ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse
Barak, L. S., Bai, Y., Peterson, S. M., Evron, T., Urs, N. M., Peddibhotla, S., Hedrick, M. P., Hershberger, P., Maloney, P., Chung, T. D. Y., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00291 · Cited by 44
Wootten, D. L., Reynolds, C. A., Smith, K. J., Mobarec, J. C., Furness, S. G. B., Miller, L. J., Christopoulos, A., & Sexton, P. M. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.015 · Cited by 44
Walker, C. S., Sundrum, T., & Hay, D. L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12541 · Cited by 43
Straiker, A. J., Wager‐Miller, J., Hutchens, J. M., & Mackie, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01744.x · Cited by 43
Mokrosiński, J., Frimurer, T. M., Sivertsen, B., Schwartz, T. W., & Holst, B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.383240 · Cited by 43
Charfi, I., Nagi, K., Mnie‐Filali, O., Thibault, D., Balboni, G., Schiller, P. W., Trudeau, L., & Piñeyro, G. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1461-7 · Cited by 43
Grotegut, C. A., Feng, L., Mao, L., Heine, R. P., Murtha, A. P., & Rockman, H. A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00390.2010 · Cited by 43
Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor
Baltos, J., Paoletta, S., Nguyen, A. T. N., Gregory, K. J., Tosh, D. K., Christopoulos, A., Jacobson, K. A., & May, L. T. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.103283 · Cited by 43
Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity
Gupta, A., Gomes, I., Bobeck, E. N., Fakira, A. K., Massaro, N. P., Sharma, I., Cavé, A., Hamm, H. E., Parello, J., & Devi, L. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521825113 · Cited by 43
Biased Signaling by Agonists of Protease Activated Receptor 2
Jiang, Y., Yau, M., Kok, W. M., Lim, J., Wu, K., Liu, L., Hill, T. A., Suen, J. Y., & Fairlie, D. P. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01088 · Cited by 43
Residues W320 and Y328 within the binding site of the μ-opioid receptor influence opiate ligand bias
Hothersall, J. D., Torella, R., Humphreys, S., Hooley, M., Brown, A., McMurray, G., & Nickolls, S. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.007 · Cited by 43
Adenosine receptors and diabetes: Focus on the A2B adenosine receptor subtype
Merighi, S., Borea, P. A., & Gessi, S. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.06.015 · Cited by 42
Newman‐Tancredi, A., Audinot, V., Moreira, C., Verrièle, L., & Millan, M. J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12477-7 · Cited by 42
Valentin-Hansen, L., Frimurer, T. M., Mokrosiński, J., Holliday, N. D., & Schwartz, T. W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.641944 · Cited by 42
Bioinformatic Approaches to Metabolic Pathways Analysis
Maudsley, S. R., Chadwick, W., Wang, L., Zhou, Y., Martin, B., & Park, S. S. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-160-4_5 · Cited by 42
Ayoub, M. A., Yvinec, R., Jégot, G., Dias, J. A., Poli, S.-M., Anne Poupon, B., Crépieux, P., & Reiter, É. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.013 · Cited by 42
Thomsen, A. R. B., Worm, J., Jacobsen, S. E., Stahlhut, M., Latta, M. R., & Bräuner‐Osborne, H. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.197210 · Cited by 41
Deng, H., Sun, H., & Ye, F. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.07.005 · Cited by 41
An optical dynamic mass redistribution assay reveals biased signaling of dualsteric GPCR activators
Kebig, A., Kostenis, E., Mohr, K., & Mohr‐Andrä, M. (2009) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890903047437 · Cited by 41
Relaxin Activates Multiple cAMP Signaling Pathway Profiles in Different Target Cells
Halls, M. L., Hewitson, T. D., Moore, X., Du, X., Bathgate, R. A. D., & Summers, R. J. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03814.x · Cited by 41
Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor Agonists
Xu, W., Wang, X., Tocker, A. M., Huang, P., Reith, M. E. A., Liu‐Chen, L., Smith, A. B., & Kortagere, S. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00221 · Cited by 40
Kuhar, J. R., Bedini, A., Melief, E. J., Chiu, Y.-C., Striegel, H. N., & Chavkin, C. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.05.019 · Cited by 39
Vecchio, E. A., Chuo, C. H., Baltos, J., Ford, L., Scammells, P. J., Wang, B. H., Christopoulos, A., White, P. J., & May, L. T. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.007 · Cited by 39
Civciristov, S., Ellisdon, A. M., Suderman, R., Pon, C. K., Evans, B. A., Kleifeld, O., Charlton, S. J., Hlavacek, W. S., Canals, M., & Halls, M. L. (2018) · Science Signaling · doi:10.1126/scisignal.aan1188 · Cited by 39
Kaya, A. İ., Onaran, H. O., Özcan, G., Ambrosio, C., Costa, T., Ballı, S., & Uğur, Ö. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.301820 · Cited by 38
Delineation of a Conserved Arrestin-Biased Signaling Repertoire In Vivo
Maudsley, S. R., Martin, B., Gesty‐Palmer, D., Cheung, H., Johnson, C. A., Patel, S., Becker, K. G., Wood, W. H., Zhang, Y., Lehrmann, E., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.095224 · Cited by 38
G protein stoichiometry dictates biased agonism through distinct receptor-G protein partitioning
Onfroy, L., Galandrin, S., Pontier, S. M., Séguélas, M., N’Guyen, D., Sénard, J., & Galès, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-07392-5 · Cited by 38
The G-protein Coupled Receptor Family: Actors with Many Faces
Liapakis, G., Cordomí, A., & Pardo, L. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799040529 · Cited by 37
Bdioui, S., Verdi, J., Pierre, N., Trinquet, E., Roux, T., & Kenakin, T. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.112573 · Cited by 37
Self-citationFollin-Arbelet, V. V., Torgersen, M. L., Naderi, E. H., Misund, K., Sundan, A., & Blomhoff, H. K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.042 · Cited by 36
Maning, J., Negussie, S., Clark, M. A., & Lymperopoulos, A. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.009 · Cited by 36
Koblish, M., Carr, R. W., Siuda, E. R., Rominger, D. H., Gowen-MacDonald, W., Cowan, C. L., Crombie, A. L., Violin, J. D., & Lark, M. W. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.241117 · Cited by 36
Wang, W. C. H., Mihlbachler, K. A., Brunnett, A. C., & Liggett, S. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906034106 · Cited by 35
Maudsley, S. R., Martin, B., Janssens, J., Etienne, H., Jushaj, A., van Gastel, J., Willemsen, A., Chen, H., Gesty‐Palmer, D., & Luttrell, L. M. (2015) · Methods · doi:10.1016/j.ymeth.2015.05.013 · Cited by 34
Islet Amyloid Polypeptide Stimulates Cyclic AMP Accumulation via the Porcine Calcitonin Receptor
Christmanson, L., Westermark, P., & Betsholtz, C. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2796 · Cited by 34
Francke, F., Ward, R. J., Jenkins, L., Kellett, E., Richter, D., Milligan, G., & Bächner, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602889200 · Cited by 34
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
Morse, M., Sun, H., Tran, E., Levenson, R. G., & Ye, F. (2013) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-14-17 · Cited by 34
Weïwer, M., Xu, Q., Gale, J. P., Lewis, M., Campbell, A. J., Schroeder, F. A., de Bittner, G. C. V., Walk, M., Amaya, A., Su, P., et al. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00168 · Cited by 34
Beyermann, M., Heinrich, N., Fechner, K., Furkert, J., Zhang, W., Kraetke, O., Bienert, M., & Berger, H. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707293 · Cited by 33
Hu, J., Stern, M. K., Gimenez, L. E., Wanka, L., Zhu, L., Rossi, M., Meister, J., Inoue, A., Beck‐Sickinger, A. G., Gurevich, V. V., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.702282 · Cited by 33
Takahashi, A., Kato, K., Kuboyama, A., Inoue, T., Tanaka, Y., Kuhara, A., Kinoshita, K., Takeda, S., & Wake, N. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.12.032 · Cited by 32
Bradley, S. J., & Tobin, A. B. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-140012 · Cited by 32
Arrestins: structural disorder creates rich functionality
Gurevich, V. V., Gurevich, E. V., & Uversky, V. N. (2018) · Protein & Cell · doi:10.1007/s13238-017-0501-8 · Cited by 31
Determination of GPCR Phosphorylation Status: Establishing a Phosphorylation Barcode
Prihandoko, R., Bradley, S. J., Tobin, A. B., & Butcher, A. J. (2015) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0213s69 · Cited by 30
Conformational Ensembles in GPCR Activation
Vardy, E., & Roth, B. L. (2013) · Cell · doi:10.1016/j.cell.2013.01.025 · Cited by 30
Liao, Y., Lu, B., Ma, Q., Wu, G., Lai, X., Zang, J., Shi, Y., Liu, D., Han, F., & Zhou, N. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.704122 · Cited by 30
Zhang, G., Cheng, J., McCorvy, J. D., Lorello, P. J., Caldarone, B. J., Roth, B. L., & Kozikowski, A. P. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00584 · Cited by 30
New thoughts on the role of the bg subunit in G protein signal transduction
Vanderbeld, B., & Kelly, G. M. (2000) · Biochemistry and Cell Biology · doi:10.1139/o00-075 · Cited by 29
Probing Biased Signaling in Chemokine Receptors
Amărandi, R.-M., Hjortø, G. M., ROSENKILDE, M. M., & Karlshøj, S. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2015.09.001 · Cited by 29
Biased agonism at chemokine receptors: obstacles or opportunities for drug discovery?
Anderson, C. A., Solari, R. C. E., & Pease, J. E. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.2mr0815-392r · Cited by 29
Corbisier, J., Huszagh, A., Galès, C., Parmentier, M., & Springael, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.757559 · Cited by 29
Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists
Molden, B., Cooney, K. A., West, K. L., der Ploeg, L. H. T. V., & Baldini, G. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1071 · Cited by 28
Tuning up the right signal: chemical and genetic approaches to study GPCR functions
Giguère, P. M., Kroeze, W. K., & Roth, B. L. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.11.006 · Cited by 28
Piñeyro, G. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.08.013 · Cited by 28
Textrous!: Extracting Semantic Textual Meaning from Gene Sets
Chen, H., Martin, B., Daimon, C. M., Siddiqui, S., Luttrell, L. M., & Maudsley, S. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062665 · Cited by 28
Teoh, J., Park, K., Wang, Y., Hu, Q., Kim, S., Wu, G., Huang, S., Maihle, N. J., & Kim, I. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.024 · Cited by 28
Santos, G. A., Duarte, D. Â., Parreiras‐e‐Silva, L. T., et al. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00131 · Cited by 27
Integrated approaches to understanding antipsychotic drug action at GPCRs
Urs, N. M., NICHOLLS, P. J., & Caron, M. G. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.11.002 · Cited by 27
β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis
Wang, Y.-D., Huang, J., Liu, X., Niu, Y., Zhao, L., Yu, Y., Zhou, L., Lü, L., & Yu, C. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00588.2016 · Cited by 27
Arrestin-Mediated Activation of p38 MAPK: Molecular Mechanisms and Behavioral Consequences
Chavkin, C., Schattauer, S. S., & Levin, J. R. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-41199-1_14 · Cited by 26
Wang, W., Wu, X., Jia, L., Zhang, H.-H., Cai, F., Mao, H., Xu, W.-C., Chen, L., Zhang, J., & Hu, S. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.038 · Cited by 26
Exploring G protein-coupled receptor signaling networks using SILAC-based phosphoproteomics
Williams, G. R., Bethard, J. R., Berkaw, M. N., Nagel, A. K., Luttrell, L. M., & Ball, L. E. (2015) · Methods · doi:10.1016/j.ymeth.2015.06.022 · Cited by 25
Lensing, C. J., Freeman, K. T., Schnell, S. M., Speth, R. C., Zarth, A. T., & Haskell‐Luevano, C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00238 · Cited by 25
Cognetti, F., Bagnato, A., Colombo, N., Savarese, A., Scambia, G., Sehouli, J., Wimberger, P., Sorio, R., Harter, P., Mari, E., et al. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.12.004 · Cited by 24
Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
Riddy, D., Cook, A. E., Diepenhorst, N. A., Bosnyak, S., Brady, R. M., la Cour, C. M., Mocaër, E., Summers, R. J., Charman, W. N., Sexton, P. M., et al. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.106153 · Cited by 24
Pharmacological Characterization of Levorphanol, a G-Protein Biased Opioid Analgesic
Rouzic, V. L., Narayan, A., Hunkle, A., Marrone, G. F., Lu, Z., Majumdar, S., Xu, J., Pan, Y., & Pasternak, G. W. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003360 · Cited by 24
Discovery of Novel FFA4 (GPR120) Receptor Agonists with β-Arrestin2-Biased Characteristics
Li, A., Yang, D., Zhu, M., Tsai, K., Xiao, K., Yu, X., Sun, J., & Du, L. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.160 · Cited by 23
Exploiting agonist biased signaling of chemokines to target cancer
Roy, I., Getschman, A. E., Volkman, B. F., & Dwinell, M. B. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22571 · Cited by 23
β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor
van der Lee, M. M. C., Verkaar, F., Wat, J. W. Y., van Offenbeek, J., Timmerman, M., Voorneveld, L., van Lith, L. H. C. J., & Zaman, G. J. R. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.11.012 · Cited by 22
A Critical Survey of Receptor Theories of Drug Action
Mackay, D. (1977) · Springer eBooks · doi:10.1007/978-3-642-66537-0_6 · Cited by 21
Protease-activated receptors (PARs) in cancer
Bar‐Shavit, R., Maoz, M., Kancharla, A., Jaber, M., Agranovich, D., Grisaru‐Granovsky, S., & Uziely, B. (2015) · Methods in cell biology · doi:10.1016/bs.mcb.2015.11.006 · Cited by 19
Edelstein, S. J., & Changeux, J. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.07.044 · Cited by 19
Studies of a ubiquitous receptor family
Roth, B. L., & Marshall, F. H. (2012) · Nature · doi:10.1038/492057a · Cited by 18
Trafficking and Function of GPCRs in the Endosomal Compartment
Calebiro, D., Godbole, A., Lyga, S., & Lohse, M. J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1755-6_16 · Cited by 18
Chun, L. S., Vekariya, R. H., Free, R. B., Li, Y., Lin, D., Su, P., Liu, F., Namkung, Y., Laporte, S. A., Moritz, A. E., et al. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00002 · Cited by 18
Eby, J. M., Abdelkarim, H., Albee, L. J., Tripathi, A., Gao, X., Volkman, B. F., Gaponenko, V., & Majetschak, M. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3044-7 · Cited by 17
New Lives for Seven Transmembrane Receptors as Drug Targets
Kenakin, T. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.09.004 · Cited by 16
Self-citationDelineating biased ligand efficacy at 7TM receptors from an experimental perspective
Galandrin, S., Onfroy, L., Poirot, M. C., Sénard, J., & Galès, C. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.04.009 · Cited by 16
Systems Analysis of Arrestin Pathway Functions
Maudsley, S. R., Siddiqui, S., & Martin, B. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394440-5.00017-6 · Cited by 16
Discovery of G Protein-Biased EP2 Receptor Agonists
Ogawa, S., Watanabe, T., Sugimoto, I., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00455 · Cited by 15
The physiological relevance of functional selectivity in dopamine signalling
Urs, N. M., & Caron, M. G. (2014) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2014.3 · Cited by 14
Jamshidi, R. J., Sullivan, L. C., Jacobs, B. A., Chavera, T. A., Berg, K. A., & Clarke, W. P. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.235184 · Cited by 14
Kurkó, D., Kapui, Z., Nagy, J., Lendvai, B., & Kolok, S. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.07.005 · Cited by 13
Melkes, B., Hejnová, L., & Novotný, J. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1293-8 · Cited by 12
Li, H., Tao, Y., Ma, L., Liu, X., & Ma, L. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1350-y · Cited by 11
Ichikawa, O., Fujimoto, K., Yamada, A., Okazaki, S., & Yamazaki, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155816 · Cited by 10
Discovery of Novel Gq-Biased LPA1 Negative Allosteric Modulators
Shimizu, Y., & Nakayama, M. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217691719 · Cited by 9
Dong, S. S., Goddard, W. A., & Abrol, R. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.07.009 · Cited by 6
Research works printed but not linked: 39
- Appleton, 2013, Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity, Methods Enzymol, 522, 229, 10.1016/B978-0-12-407865-9.00013-3 · doi:10.1016/b978-0-12-407865-9.00013-3
- Audet, 2008, Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins, J Biol Chem, 283, 15078, 10.1074/jbc.M707941200 · doi:10.1074/jbc.m707941200
- Aurelio, 2018, A structure-activity relationship study of bitopic N6-substituted adenosine derivatives as biased adenosine A1 receptor agonists, J Med Chem, 61, 2087, 10.1021/acs.jmedchem.8b00047 · doi:10.1021/acs.jmedchem.8b00047
- Coffa, 2011, A single mutation in arrestin-2 prevents ERK1/2 activation by reducing c-Raf1 binding, Biochemistry, 50, 6951, 10.1021/bi200745k · doi:10.1021/bi200745k
- Coffman, 1997, A genetic approach for studying the physiology of the type 1A (AT1A) angiotensin receptor, Semin Nephrol, 17, 404
- Cook, 2015, Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics, Br J Pharmacol, 172, 185, 10.1111/bph.12937 · doi:10.1111/bph.12937
- Coward, 1998, Controlling signaling with a specifically designed Gi-coupled receptor in transgenic mice, Nat Biotechnol, 17, 165
- Daugvilaite, 2017, Biased agonism and allosteric modulation of G protein-coupled receptor 183 - a 7TM receptor also known as Epstein-Barr virus-induced gene 2, Br J Pharmacol, 174, 2031, 10.1111/bph.13801 · doi:10.1111/bph.13801
- Fang, 2008, Label-free optical biosensor for ligand-directed functional selectivity acting on beta(2) adrenoceptor in living cells, FEBS Lett, 582, 558, 10.1016/j.febslet.2008.01.021 · doi:10.1016/j.febslet.2008.01.021
- Ferrari, 2017, In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403, Pharmacol Res Perspect, 5, 10.1002/prp2.333 · doi:10.1002/prp2.333
- Fisher, 1993, Selective signaling via unique M1 muscarinic agonists, Ann N Y Acad Sci, 695, 300, 10.1111/j.1749-6632.1993.tb23070.x · doi:10.1111/j.1749-6632.1993.tb23070.x
- Gesty-Palmer, 2011, ‘Biasing’ the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass?, Br J Pharmacol, 164, 59, 10.1111/j.1476-5381.2011.01450.x · doi:10.1111/j.1476-5381.2011.01450.x
- Heldman, 1996, Pharmacological basis for functional selectivity of partial muscarinic receptor agonists, Eur J Pharmacol, 297, 283, 10.1016/0014-2999(95)00745-8 · doi:10.1016/0014-2999(95)00745-8
- Hoffmann, 2008, Agonist-selective, receptor-specific interaction of human P2Y receptors with β-arrestin-1 and -2, J Biol Chem, 283, 30933, 10.1074/jbc.M801472200 · doi:10.1074/jbc.m801472200
- Hou, 2016, Label-free cell phenotypic profiling and pathway deconvolution of neurotensin receptor-1, Pharmacol Res, 108, 39, 10.1016/j.phrs.2016.04.018 · doi:10.1016/j.phrs.2016.04.018
- Jozwiak, 2010, The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor, Biochem Pharmacol, 79, 1610, 10.1016/j.bcp.2010.01.035 · doi:10.1016/j.bcp.2010.01.035
- Kenakin, 2012, Casting a wider net: whole-cell assays to capture varied and biased signaling, Mol Pharmacol, 82, 571, 10.1124/mol.112.081117 · doi:10.1124/mol.112.081117
- Kenakin, 1985, Prenalterol as a selective cardiostimulant: differences between organ and receptor selectivity, J Cardiovasc Pharmacol, 7, 208, 10.1097/00005344-198501000-00033 · doi:10.1097/00005344-198501000-00033
- Kenakin, 2016, Synoptic pharmacology: detecting and assessing the pharmacological significance of ligands for orphan receptors, Pharmacol Res, 114, 284, 10.1016/j.phrs.2016.01.022 · doi:10.1016/j.phrs.2016.01.022
- Kenakin, 1991, The relative efficiency of beta adrenoceptor coupling to myocardial inotropy and diastolic relaxation: organ-selective treatment for diastolic dysfunction, J Pharmacol Exp Ther, 257, 1189, 10.1016/S0022-3565(25)24731-0 · doi:10.1016/s0022-3565(25)24731-0
- Lawler, 1994, Discrete functional selectivity of drugs: OPC-14597, a selective antagonist for post-synaptic dopamine D2 receptors (Abstract), Soc Neurosci Abstr, 20, 525
- Longabaugh, 1988, Decreased stimulatory guanosine triphosphate binding protein in dogs with pressure-overload left ventricular failure, J Clin Invest, 81, 420, 10.1172/JCI113335 · doi:10.1172/jci113335
- Maguire, 2016, Evidence for biased agonists and antagonists at the endothelin receptors, Life Sci, 159, 30, 10.1016/j.lfs.2016.02.069 · doi:10.1016/j.lfs.2016.02.069
- Maillet, 2007, A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties, FASEB J, 21, 2124, 10.1096/fj.06-7683com · doi:10.1096/fj.06-7683com
- McAnally, 2017, A systematic approach to identify biased agonists of the apelin receptor through high-throughput screening, SLAS Discov, 22, 867, 10.1177/2472555217699158 · doi:10.1177/2472555217699158
- Michal, 2007, Muscarinic M2 receptors directly activate Gq/11 and Gs G-proteins, J Pharmacol Exp Ther, 320, 607, 10.1124/jpet.106.114314 · doi:10.1124/jpet.106.114314
- Milanos, 2016, Discovery and characterization of biased allosteric agonists of the chemokine receptor CXCR3, J Med Chem, 59, 2222, 10.1021/acs.jmedchem.5b01965 · doi:10.1021/acs.jmedchem.5b01965
- Milanos, 2016, Identification of two distinct sites for antagonist and biased agonist binding to the human chemokine receptor CXCR3, Angew Chem Int Ed Engl, 55, 15277, 10.1002/anie.201607831 · doi:10.1002/anie.201607831
- Mottola, 1991, Dihydrexidine, a selective dopamine receptor agonist that may discriminate postsynaptic D2 receptors, Abstr Soc Neurosci, 17, 818
- Nasman, 2001, Role of G-protein availability in differential signaling by alpha 2-adrenoceptors, Biochem Pharmacol, 62, 913, 10.1016/S0006-2952(01)00730-4 · doi:10.1016/s0006-2952(01)00730-4
- Ogawa, 2016, Structural optimization and structure-functional selectivity relationship studies of G protein-biased EP2 receptor agonists, Bioorg Med Chem Lett, 26, 2446, 10.1016/j.bmcl.2016.03.110 · doi:10.1016/j.bmcl.2016.03.110
- Peverelli, 2013, Specific roles of G(i) protein family members revealed by dissecting SST5 coupling in human pituitary cells, J Cell Sci, 126, 638, 10.1242/jcs.116434 · doi:10.1242/jcs.116434
- Roerig, 1992, Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells, Mol Pharmacol, 41, 822, 10.1016/S0026-895X(25)09122-9 · doi:10.1016/s0026-895x(25)09122-9
- Seo, 2011, Identification of arrestin-3-specific residues necessary for JNK3 kinase activation, J Biol Chem, 286, 27894, 10.1074/jbc.M111.260448 · doi:10.1074/jbc.m111.260448
- Tang, 1998, Native protein fluctuations: the conformational-motion temperature and the inverse correlation of protein flexibility with protein stability, J Biomol Struct Dyn, 16, 397, 10.1080/07391102.1998.10508256 · doi:10.1080/07391102.1998.10508256
- Tucek, 1997, Is the R and R dichotomy real?, Trends Pharmacol Sci, 18, 414, 10.1016/S0165-6147(97)90672-6 · doi:10.1016/s0165-6147(97)90672-6
- Ward, 1995, Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles, J Med Chem, 38, 3469, 10.1021/jm00018a007 · doi:10.1021/jm00018a007
- Woo, 2017, Biased agonism at the angiotensin receptor: blocker and calcium sensitizer at the same time, Circulation, 135, 1071, 10.1161/CIRCULATIONAHA.117.027276 · doi:10.1161/circulationaha.117.027276
- Zhou, 2018, An operational model for GPCR homodimers and its application in the analysis of biased signaling, Drug Discov Today, 23, 1591, 10.1016/j.drudis.2018.04.004 · doi:10.1016/j.drudis.2018.04.004
Cited by
TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome
Olsen, R. H. J., DiBerto, J. F., English, J. G., Glaudin, A. M., Krumm, B. E., Slocum, S. T., Che, T., Gavin, A. C., McCorvy, J. D., Roth, B. L., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0535-8 · Cited by 544
Review of the Endocannabinoid System
Lu, H.-C., & Mackie, K. (2021) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.07.016 · Cited by 491
GPCR activation mechanisms across classes and macro/microscales
Hauser, A. S., Kooistra, A. J., Munk, C., Heydenreich, F. M., Veprintsev, D. B., Bouvier, M., Babu, M. M., & Gloriam, D. E. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00674-7 · Cited by 301
Virtual discovery of melatonin receptor ligands to modulate circadian rhythms
Stein, R. M., Kang, H. J., McCorvy, J. D., Glatfelter, G. C., Jones, A. J., Che, T., Slocum, S., Huang, X.-P., Savych, O., Moroz, Y. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2027-0 · Cited by 298
Self-citationMolecular basis of β-arrestin coupling to formoterol-bound β1-adrenoceptor
Lee, Y., Warne, T., Nehmé, R., Pandey, S., Dwivedi-Agnihotri, H., Chaturvedi, M., Edwards, P. C., García-Nafría, J., Leslie, A. G. W., Shukla, A. K., et al. (2020) · Nature · doi:10.1038/s41586-020-2419-1 · Cited by 295
Metadata
- Authors
- Kenakin, T.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 71
- Issue
- 2
- Pages
- 267-315
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2923681300
- Cited by
- 294
- References
- 525
- FWCI
- 10.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.